Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor

Area of Science:

• Pharmacology
• Genetics
• Molecular Biology

Background:

• The cannabinoid receptor 2 (CB2) gene plays a role in various physiological processes.
• Nonsynonymous single nucleotide polymorphisms (SNPs) in the CB2 gene may impact receptor function.

Purpose of the Study:

• To investigate the functional consequences of two specific nonsynonymous SNPs in the human CB2 receptor gene.
• To determine how Q63R and H316Y mutations affect CB2 receptor activity.

Main Methods:

• Site-directed mutagenesis was used to create Q63R, H316Y, and Q63R/H316Y mutations in the human CB2 receptor.
• Mutant CB2 receptors were stably transfected into HEK293 cells for functional assays.
• Ligand binding, ligand-induced activity (cyclic AMP accumulation), and constitutive activity assays were performed.

Main Results:

• CB2 polymorphic receptors maintained ligand binding and signal transduction capabilities.
• Reduced efficacy of cannabinoid agonists (WIN55212-2, 2-arachidonoylglycerol) was observed with polymorphic receptors.
• H316Y and Q63R/H316Y polymorphic receptors showed increased constitutive activity compared to wild-type CB2.

Conclusions:

• Polymorphisms at positions 63 and 316 significantly alter CB2 receptor function.
• These functional alterations suggest that CB2 polymorphic receptors may be implicated in the etiology of certain diseases.